TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
|
|
|
|||
1. Identity of the issuer or the underlying issuer |
Spire Healthcare Group plc |
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
X |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
X |
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
||||
An event changing the breakdown of voting rights |
||||
Other (please specify): |
|
|||
3. Full name of person(s) subject to the |
The Goldman Sachs Group, Inc. |
|||
4. Full name of shareholder(s) |
Goldman Sachs International Goldman, Sachs & Co. GS Investment Strategies, LLC |
|||
5. Date of the transaction and date on |
13 February 2017 |
|||
6. Date on which issuer notified: |
15 February 2017 |
|||
7. Threshold(s) that is/are crossed or |
Above 3% |
|||
8. Notified details: |
||||||||||||||||||||||||||||||||||||||||||
A: Voting rights attached to shares viii, ix |
||||||||||||||||||||||||||||||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||||||||||||||||||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights x |
||||||||||||||||||||||||||||||||||||||
Direct |
Direct xi |
Indirect xii |
Direct |
Indirect |
||||||||||||||||||||||||||||||||||||||
GB00BNLPYF73 |
Below 3% |
Below 3% |
|
|
6,946,370 |
|
1.732% |
|||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||||||||||||||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||||||||||||||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||||||||||||||||||||||||||||||
Stock Loan (Physical) |
Open |
|
5,097,404 |
1.271% |
||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
Total (A+B+C) |
||||||||||||||||||||||||||||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||||||||||||||||||||||||||||
12,043,774 |
3.003% |
|||||||||||||||||||||||||||||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||
-----------------The Goldman Sachs Group, Inc.; 12,043,774 shares; 3.003%
Goldman Sachs (UK) L.L.C. (Controlled by The Goldman Sachs Group, Inc.) Goldman Sachs Group UK Limited (Controlled by Goldman Sachs (UK) L.L.C.) Goldman Sachs International (Controlled by Goldman Sachs Group UK Limited)
The Goldman, Sachs & Co. L.L.C. (Controlled by The Goldman Sachs Group, Inc.) Goldman, Sachs & Co. (Controlled by The Goldman, Sachs & Co. L.L.C.)
GSAM Holdings LLC (Controlled by The Goldman Sachs Group, Inc.) GS Investment Strategies, LLC (Controlled by GSAM Holdings LLC)
|
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
N/A |
|
11. Number of voting rights proxy holder will cease |
N/A |
|
12. Date on which proxy holder will cease to hold |
N/A |
|
|
||
|
Please note, total amount of voting rights have been rounded to 3 decimal places therefore there is a possibility of a rounding error.
General email contact:
|
|
14. Contact name: |
Joanna Foley |
|
15. Contact telephone number: |
|
|